Search Results 1781-1790 of 21497 for platelets

  1. A Study to Evaluate the Safety, Effectiveness, and Tolerability of Latiglutenase to Treat Patients with Well-Controlled Celiac Disease - Mayo Clinic

    Platelet count< 75.0 x 109/L or 75,000/mm3;; Partial thromboplastin time (PTT) or prothrombin time (PT/INR) > 1.5 ULN;; Serum potassium < 3.0 mmol/L, > 5 mmol ...

  2. Siegel TAVR in Aortic Severe Stenosis - Mayo Clinic

    Blood dyscrasias as defined: leukopenia (WBC < 3000 cell/mL, anemia (Hgb < 9 g/dL), thrombocytopenia (platelet count < 50,000 cells/mL), history of bleeding ...

  3. Many Hands Make Hopeful Work for Nielsen Boys - Mayo Clinic News Network

    The condition inhibits the body's ability to produce platelets, the blood cells that help keep bleeding under control. Grant's only hope for a cure was a ...

  4. Clinical Trials - 2020 Archives

    ... Largest pharmacogenetic clinical trial in cardiology shows potential benefit in individualized approach to anti-platelet therapy. Terri Malloy.

  5. Durvalumab and Grid Therapy for the Treatment of Non-small Cell Lung Cancer in Patients Who Progressed During or After Treatment With the PACIFIC Regimen - Mayo Clinic

    Platelet count ≥ 100,000/mm^3;; Total bilirubin ≤ 1.5 x ULN or direct bilirubin ≤ULN if total bilirubin is > 1.5 x ULN;; Alanine aminotransferase (ALT) and ...

  6. A Study of BMS-813160 in Combination with Chemotherapy or Nivolumab in Patients with Advanced Solid Tumors BMS-813160 in Combination With Chemotherapy or Nivolumab in Patients With Advanced Solid Tumors - Mayo Clinic

    Platelets ≥ 100 x 103/µL; > 75,000/µL allowed for Arms C and D; Hemoglobin ≥ 8.5 g/dL. Adequate other organ functions as defined by the following: Alanine ...

  7. A Study to Evaluate the Veniti Vici™ Venous Stent System in Patients with a Chronic Iliofemoral Venous Outflow Obstruction - Mayo Clinic

    Platelet count <80,000; Uncorrected hemoglobin of ≤ 9 g/dL. Has an estimated glomerular filtration rate (eGFR) <30 mL/min. In patients with diabetes mellitus ...

  8. Finding an Effective Dose of GM1 to Reduce or Prevent Neuropathy (Numbness or Weakness) Due to Treatment With Paclitaxel (Phase II) - Mayo Clinic

    - Platelet count >= 100,000/mm^3 - Creatinine =< 1.5 x upper limit of normal (ULN) - Aspartate aminotransferase (AST) or alanine aminotransferase (ALT) ...

  9. Study to Investigate the Safety, Pharmacokinetic Profiles and the Efficacy of Tinostamustine, a First-in-Class Alkylating Histone Deacetylase Inhibition Fusion Molecule, in Relapsed/Refractory Hematologic Malignancies - Mayo Clinic

    Eastern Cooperative Oncology Group (ECOG) performance status ≤2; Neutrophils >1,000 µL; Platelets ≥75,000 µL; Aspartate aminotransferase/alanine ...

  10. Pterygopalatine Fossa Treatment for Acute Headache in Aneurysmal - Mayo Clinic

    Infected or wounded skin, or a skin lesion at the site of puncture for PPF- injection. Uncorrected coagulopathy. Platelet count < 50,000/μL, International ...